The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiplexed analysis of myeloid cell (MC) markers to characterize the innate immune composition and clinical features of human non-small cell lung carcinomas (NSCLC).
 
Brian S. Henick
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Boehringer Ingelheim
 
Ila Datar
No Relationships to Disclose
 
Franz Villarroel-Espindola
No Relationships to Disclose
 
Miguel F. Sanmamed
No Relationships to Disclose
 
Jovian Yu
No Relationships to Disclose
 
Rasikh Tuktamyshov
Stock and Other Ownership Interests - Gilead Sciences; Novartis
 
Alice Chuan Li
No Relationships to Disclose
 
Maria Toki
No Relationships to Disclose
 
Konstantinos N. Syrigos
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Genentech
Consulting or Advisory Role - Agendia; AstraZeneca; Bethyl Laboratories; Biocept; Bristol-Myers Squibb; Clearsight; Five Prime Therapeutics; Genoptix; Merck; Optra SCAN; Perkin Elmer; Ultivue
Research Funding - AstraZeneca/MedImmune (Inst); Cepheid; Gilead Sciences; NextCure (Inst); OncoPlex Diagnostics; Perkin Elmer; Pierre Fabre (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Genentech; NextCure; Ventana Medical Systems
 
Lieping Chen
No Relationships to Disclose
 
Roy S. Herbst
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Lilly; Merck; Pfizer
Research Funding - Genentech; Merck
 
Kurt A. Schalper
Honoraria - Takeda
Consulting or Advisory Role - Celgene; Shattuck Labs
Research Funding - Moderna Therapeutics; Navigate BioPharma; Onkaido Therapeutics; Pierre Fabre; Surface Oncology; Takeda; Tesaro; Vasculox